These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 25317960)

  • 1. Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection.
    Yusuf E; Perrottet N; Orasch C; Borens O; Trampuz A
    Surg Infect (Larchmt); 2014 Dec; 15(6):834-7. PubMed ID: 25317960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin-induced eosinophilic pneumonia.
    Hassett MR
    JAAPA; 2024 Apr; 37(4):1-4. PubMed ID: 38531037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review.
    Di Lorenzo A; Rindi LV; Campogiani L; Imeneo A; Alessio G; Pace PG; Lodi A; Rossi B; Crea AMA; Vitale P; Kontogiannis D; Malagnino V; Andreoni M; Iannetta M; Sarmati L
    Chemotherapy; 2024; 69(2):85-99. PubMed ID: 37963447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced eosinophilic pneumonia: A review of 196 case reports.
    Bartal C; Sagy I; Barski L
    Medicine (Baltimore); 2018 Jan; 97(4):e9688. PubMed ID: 29369189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare Lung Malignancy Mimic: A Case of Daptomycin-Induced Acute Eosinophilic Pneumonia.
    Bowie RA; Nguyen CQ; Seemann LL; Clapp AD
    Cureus; 2024 Mar; 16(3):e56106. PubMed ID: 38618432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic Pneumonia Induced by Daptomycin.
    Ayala Torres JD; NoreƱa B; Suarez Poveda AT
    Cureus; 2024 Feb; 16(2):e55095. PubMed ID: 38558746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin-induced eosinophilic pneumonia - a systematic review.
    Uppal P; LaPlante KL; Gaitanis MM; Jankowich MD; Ward KE
    Antimicrob Resist Infect Control; 2016; 5():55. PubMed ID: 27999664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin Exposure as a Risk Factor for Daptomycin-Induced Eosinophilic Pneumonia and Muscular Toxicity.
    Garreau R; Pham TT; Bourguignon L; Millet A; Parant F; Bussy D; Desevre M; Franchi V; Ferry T; Goutelle S
    Clin Infect Dis; 2023 Nov; 77(10):1372-1380. PubMed ID: 37467019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed Response to Glucocorticoids in Daptomycin Lung.
    Nanah A; Nair AS; Stoller J
    Am J Ther; 2024 Jul-Aug 01; 31(4):e518-e521. PubMed ID: 38526291
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute Eosinophilic Pneumonia Secondary to Daptomycin.
    Somoza-Cano FJ; Makadia A; Cruz-Peralta MP; Zakarna L; Demyda E; Al Armashi AR; Patell K; Altaqi B
    Cureus; 2021 Nov; 13(11):e19403. PubMed ID: 34926005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin-Induced Eosinophilic Pneumonia: Can an Antibiotic Cause Pneumonia?
    Saeed S; Salam E; Weaver M; Tahir S; Bansal A
    Cureus; 2024 Feb; 16(2):e55298. PubMed ID: 38562262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daptomycin-associated pulmonary toxicity sans eosinophilia in a hematopoietic cell transplant recipient with profound leukopenia.
    Zou J; Rivera Sarti JE; Strasfeld L
    Transpl Infect Dis; 2023 Jun; 25(3):e14029. PubMed ID: 36787236
    [No Abstract]   [Full Text] [Related]  

  • 13. Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series.
    Gidari A; Pallotto C; Francisci D
    Infection; 2024 Jul; ():. PubMed ID: 39028390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection.
    Soldevila-Boixader L; Villanueva B; Ulldemolins M; Benavent E; Padulles A; Ribera A; Borras I; Ariza J; Murillo O
    Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33923382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin pharmacokinetic/pharmacodynamic target in staphylococcal infections.
    Garreau R; Pham TT; Bourguignon L; Millet A; Parant F; Bussy D; Desevre M; Franchi V; Ferry T; Goutelle S
    Clin Infect Dis; 2024 Jan; ():. PubMed ID: 38236297
    [No Abstract]   [Full Text] [Related]  

  • 16. Is a high baseline inflammatory burden the major driver in causing daptomycin-induced eosinophilic pneumonia and muscular toxicity?
    Gatti M; Pea F
    Clin Infect Dis; 2024 Jan; ():. PubMed ID: 38236203
    [No Abstract]   [Full Text] [Related]  

  • 17. Daptomycin-induced acute eosinophilic pneumonia.
    Patel JJ; Antony A; Herrera M; Lipchik RJ
    WMJ; 2014 Oct; 113(5):199-201. PubMed ID: 25739164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyspnea on daptomycin: eosinophilic pneumonia.
    Wojtaszczyk A; Jankowich M
    R I Med J (2013); 2015 Jun; 98(6):41-3. PubMed ID: 26020264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin-Induced Acute Eosinophilic Pneumonia: Late Onset and Quick Recovery.
    Rachid M; Ahmad K; Saunders-Kurban M; Fatima A; Shah A; Nahhas A
    Case Rep Pulmonol; 2017; 2017():8525789. PubMed ID: 29225987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two patients with daptomycin induced eosinophilic pneumonia with different presentations and treatment.
    Raru Y; Zeid F; Browning S; Saunders E
    Respir Med Case Rep; 2018; 23():29-32. PubMed ID: 29201637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.